Citigroup analysts raised their price target on Celgene Corp. (NASDAQ: CELG) from $68 to $73, while maintaining a Buy rating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE